id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
bam-14272	Lei, Wang; Min, Hu; Yue, Chen; Gejun, Zhang; Chao, Wei; Qian, Liu	Analysis of the Effects of Dapagliflozin on Cardiac Myocyte Injury Markers and Left Ventricular Diastolic Function in Heart Failure Patients with Preserved Ejection Fraction after PCI	2025	10	.pdf	application/pdf	2660	134	42	In conclusion, Dapagliflozin effectively reduces cardiac myocyte injury markers, improves left ventricular diastolic function, and lowers the incidence of MACE in HF-PEF patients after PCI, demonstrating significant translational benefits for cardiac muscle function. Clinical manifestations include dyspnea, respiratory distress, lower extremity edema, and fatigue.1-2 The occurrence of HF-PEF significantly increases the incidence of Major Adverse Cardiovascular Events (MACE), posing substantial risks to patient safety.3 While routine antiplatelet therapy after PCI can improve cardiac function and alleviate symptoms, its overall efficacy remains suboptimal.4	cache/bam-14272.pdf	txt/bam-14272.txt